These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 751446)

  • 1. [Updating haloperidol: 1975].
    Ayd FJ
    Acta Physiol Lat Am; 1978 Sep; 24(3):233-8. PubMed ID: 751446
    [No Abstract]   [Full Text] [Related]  

  • 2. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
    Gallant DM; Bishop M; Guerrero-Figueroa R
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo differentiation of cardiac vagal blocking effects of chlorpromazine and haloperidol.
    Schreiber G; Belmaker RH
    Biol Psychiatry; 1987 Nov; 22(11):1417-21. PubMed ID: 3663793
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
    Balon R; Berchou R; Zethelius M
    Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute and chronic psychoses with haloperidol: review of clinical results.
    Ban TA
    Curr Ther Res Clin Exp; 1969 May; 11(5):284-8. PubMed ID: 4977400
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
    Singh MM
    Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm maintenance therapy with depot haloperidol in schizophrenia.
    Zbytovský J
    Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative results of pharmacologic loading with aminazine and heloperidol in the treatment of the simple form of schizophrenia (according to pain sensography findings)].
    Almazov BN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(9):1397-1401. PubMed ID: 4423309
    [No Abstract]   [Full Text] [Related]  

  • 11. Two cases of deep vein thrombosis associated with antipsychotic drug use.
    Matsumoto M; Konno T; Tamba K; Abe T; Kato S; Kajii E
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):450-1. PubMed ID: 15298663
    [No Abstract]   [Full Text] [Related]  

  • 12. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
    Ozola MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sulpiride: a neuroleptic agent of new generation with unique pharmacological qualities and rather wide range of clinical applications].
    Pawłowski L
    Psychiatr Pol; 1993; 27(2):199-205. PubMed ID: 8104350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol versus chlorpromazine for treatment of schizophrenia.
    Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
    Schizophr Bull; 2008 Sep; 34(5):813-5. PubMed ID: 18658127
    [No Abstract]   [Full Text] [Related]  

  • 15. Voltage laterality in the EEG of psychiatric patients.
    Serafetinides EA
    Dis Nerv Syst; 1973 Mar; 34(3):190-1. PubMed ID: 4715636
    [No Abstract]   [Full Text] [Related]  

  • 16. Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.
    Thompson TR; Lal S; Yassa R; Gerstein W
    Acta Psychiatr Scand; 1988 Dec; 78(6):763-5. PubMed ID: 3223334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol in overt ambulatory schizophrenics.
    Darling HF
    Dis Nerv Syst; 1973; 34(7):364-7. PubMed ID: 4782293
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum lipids and lipoproteins in schizophrenic patients receiving major tranquilizers.
    Shafique M; Khan IA; Akhtar MH; Hussain I
    J Pak Med Assoc; 1988 Oct; 38(10):259-61. PubMed ID: 3144603
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
    Zolotnitskii RI; Kutsenok BM; Gastev MD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(5):750-4. PubMed ID: 5363890
    [No Abstract]   [Full Text] [Related]  

  • 20. Ataractic drugs versus ECT in schizophrenia.
    Spensley J
    Am J Psychiatry; 1973 Oct; 130(10):1162-3. PubMed ID: 4728918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.